Meridia National Class Action

If you wish to be kept advised of the status of the Meridia® class action lawsuits and any resulting compensation program resulting from this litigation in Canada, please provide your contact information to our law firm using the below form. Please note, filling out the form below creates no financial obligation for you.

Meridia® is a prescription diet pill prescribed to individuals suffering from obesity. Generic versions of Meridia® were also marketed in Canada as Apo-Sibutramine and Novo-Sibutramine. Please note, our law firm is not in a position to provide any form of medical advice, and if you have any questions of a medical nature you should refer them to your doctor.

ONTARIO RESIDENTS: The following notice is being posted to this webpage pursuant to this

Ontario Court Order (5 March 2012)

which you are encouraged to read in PDF

To Ontario Residents:

This is an important notice for individuals who took Meridia® that may affect their legal rights.

A proposed class action against the makers of Meridia®, Abbott Laboratories, Ltd. and Abbott Laboratories, was commenced in Ontario on October 13, 2010, arising from the drug’s alleged adverse health effects. Proposed class actions were also commenced in British Columbia on February 16, 2011 on behalf of B.C. residents and any non-residents who choose to opt in, and in Saskatchewan on February 4, 2011 on behalf of all Canadian residents. The Ontario class action has been permanently stayed because the plaintiffs are not willing to move forward in Ontario at this time. This means the Ontario class action will not be going forward.

When a proposed class action is commenced, the limitation period is suspended for class members until the action is dismissed, stayed, or discontinued. The law is uncertain, but the general consensus of Ontario lawyers is that the filing of the actions in B.C. or Saskatchewan suspended the limitation period for residents of Ontario as well. If this is correct, Ontario class members will be able to opt into the B.C. action if it is certified (or automatically be included in the Saskatchewan action, unless they opt out). The B.C. proceeding is moving forward, but it is uncertain when, or if, it will be certified.

Former users of Meridia® who wish to commence an individual claim or who do not want to risk being unable to join a class action in another province should immediately seek the advice of a lawyer licensed to practice in Ontario.

Recours collectif concernant Meridia® – Toute personne au Québec ayant consommé le produit Meridia, un comprimé coupe-faim prescrit aux gens souffrant d’obésité, qu’elle ressente ou non des effets secondaires, peut communiquer avec notre cabinet de Montréal (sans obligation) en remplissant le formulaire ci-dessous, en téléphonant au 514 842-7776 ou par courriel à :

Merchant Law Group LLP has 10 offices across Canada, with lawyers practising law in six provinces. Merchant Law Group LLP and Tony Merchant, Q.C. are well known for pursuing class action lawsuits in Canada including litigation regarding Winners/HomeSense, Various Cellular Phone Fees, BCE Dividends, GM Gasket Manifolds, Hip Implants, Lead Paint in Toys (and similar consumer products), Maple Leaf, Celebrex/Bextra, Vioxx, Sony, Residential Schools and various other cases. Tony Merchant, Q.C. is known to be one of Canada’s most active litigators with more than 600 reported cases in leading Caselaw Journals, having argued thousands of cases before the Canadian and American Courts, in Trial and Administrative Courts, and the Courts of Appeal of various American and Canadian jurisdictions, the Federal Court of Canada, and the Supreme Court of Canada. Tony Merchant, Q.C., has a long history in pursuing public policy cases and is a former Member of the Legislative Assembly (M.L.A.)

(Please note, providing your information creates no financial obligation for you. You are not charged any fee or cost for joining this class action – our law firm is paid a contingency fee from the compensation recovered, if the class action is successful.)